Intra-Cellular Therapies Pre-Paid Expenses 2013-2024 | ITCI

Intra-Cellular Therapies pre-paid expenses for the quarter ending September 30, 2024 were $0.094B, a 52.06% increase year-over-year.

  • Intra-Cellular Therapies pre-paid expenses for 2023 were $0.042B, a 6.09% decline from 2022.
  • Intra-Cellular Therapies pre-paid expenses for 2022 were $0.045B, a 77.62% increase from 2021.
  • Intra-Cellular Therapies pre-paid expenses for 2021 were $0.025B, a 78.73% increase from 2020.

Intra-Cellular Therapies Pre-Paid Expenses 2013-2024 | ITCI

  • Intra-Cellular Therapies pre-paid expenses for 2023 were $0.042B, a 6.09% decline from 2022.
  • Intra-Cellular Therapies pre-paid expenses for 2022 were $0.045B, a 77.62% increase from 2021.
  • Intra-Cellular Therapies pre-paid expenses for 2021 were $0.025B, a 78.73% increase from 2020.